Regulation of membrane-associated iPLA2 activity by a novel PKC isoform in ventricular myocytes

American Journal of Physiology - Cell Physiology

Volumn 283, Issue 6 52-6, 2002, Pages

  Steer, Sarah A ^a   Wirsig, Karin C ^a   Creer, Michael H ^a   Ford, David A ^a   McHowat, Jane ^a  

^a SAINT LOUIS UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Calcium independent phospholipase A2; Protein kinase C; Signal transduction; Ventricular myocytes

Indexed keywords

2 [1 (3 DIMETHYLAMINOPROPYL) 3 INDOLYL] 3 (3 INDOLYL)MALEIMIDE; ARACHIDONIC ACID; CALCIUM INDEPENDENT PHOSPHOLIPASE A2; ISOENZYME; LYSOPLASMENYLCHOLINE; MEMBRANE PHOSPHOLIPID; PHOSPHOLIPASE A2; PLASMALOGEN; PROTEIN KINASE C; PROTEIN KINASE C INHIBITOR; THROMBIN; UNCLASSIFIED DRUG;

ANIMAL CELL; ARTICLE; CELL MEMBRANE; CONTROLLED STUDY; ENZYME ACTIVITY; ENZYME REGULATION; FATTY ACID SYNTHESIS; HEART MUSCLE CELL; IMMUNOBLOTTING; LIPID HYDROLYSIS; NONHUMAN; PHOSPHOLIPID SYNTHESIS; PRIORITY JOURNAL; RABBIT; SIGNAL TRANSDUCTION;

ANIMALIA; ORYCTOLAGUS CUNICULUS; TRIXIS;

EID: 0036889004     PISSN: 03636143     EISSN: None     Source Type: Journal    
DOI: 10.1152/ajpcell.00109.2002     Document Type: Article

References (30)

1. Albert CJ and Ford DA. Protein kinase C translocation and PKC-dependent protein phosphorylation during myocardial ischemia. Am J Physiol Heart Circ Physiol 276: H642-H650, 1999.
2. Bell RM and Burns DJ. Lipid activation of protein kinase C. J Biol Chem 266: 4661-4664, 1991.
3. 2+-sensitive isoforms in the failing heart. Circulation 99: 384-391, 1999.
4. 2. Biochim Biophys Acta 1215: 115-120, 1994.
5. 2 expressed in the heart. J Mol Cell Cardiol 29: 2095-2106, 1997.
6. Dom II GW, Souroujon MC, Liron T, Chen CH, Gray MO, Zhou HZ, Csukai M, Wu G, Lorenz JN, and Mochly-Rosen D. Sustained in vivo cardiac protection by a rationally designed peptide that causes ε protein kinase C translocation. Proc Natl Acad Sci USA 96: 12798-12803, 1999.
7. 2 by depletion of internal calcium stores. Biochem Soc Trans 26: 345-349, 1998.
8. 2. J Biol Chem 266: 14526-14534, 1991.
9. 2. Implications for the coordinated regulation of phospholipolysis and glycolysis. J Biol Chem 268: 9892-9900, 1993.
10. 2 isoform. Fast atom bombardment mass spectroscopic and reverse-phase high pressure liquid chromatography identification of choline and ethanolamine glycerophospholipid substrates. J Clin Invest 91: 2513-2522, 1993.
11. Inoguchi T, Battan R, Handler E, Sportsman Jr, Heath W, and King GL. Preferential elevation of protein kinase C isoform βII and diacylglycerol levels in the aorta and heart of diabetic rats: Differential reversibility to glycemic control by islet cell transplantation. Proc Natl Acad Sci USA 89: 11059-11063, 1992.
12. 2 gene. Multiple enzymes with distinct properties from a single gene. Eur J Biochem 262: 575-585, 1999.
13. 2 and adenylyl cyclase by phorbol ester in RAW264.7 macrophages. Br J Pharmacol 125: 1601-1609, 1998.
14. 2 isoforms by TNF-α and IL-1β in adult rat ventricular myocytes. Am J Physiol Heart Circ Physiol 275: H1462-H1472, 1998.
15. Liu Y, Ytrehus K, and Downey JM. Evidence that translocation of protein kinase C is a key event during ischemic preconditioning of rabbit myocardium. J Mol Cell Cardiol 26: 661-668, 1994.
16. Livneh E and Fishman DD. Linking protein kinase C to cell-cycle control. Eur J Biochem 248: 1-9, 1997.
17. 2. J Biol Chem 275: 9937-9945, 2000.
18. Markwell MAK, Haas SM, Tolbert NE, and Bieber LL. Protein determination in membrane and lipoprotein samples: Manual and automated procedures. Methods Enzymol 72: 296-303, 1981.
19. 2 in ventricular myocytes. Am J Physiol Cell Physiol 274: C447-C454, 1998.
20. 2 in isolated rabbit ventricular myocytes. Lipids 33: 1203-1212, 1998.
21. 2 in cardiomyocytes. Am J Physiol Heart Circ Physiol 278: H1933-H1940, 2000.
22. McHowat J, Yamada KA, Wu J, Yan G-X, and Corr PB. Recent insights pertaining to sarcolemmal phospholipids alterations underlying arrhythmogenesis in the ischemic heart. J Cardiovasc Electrophysiol 4: 288-310, 1993.
23. Nakamura S and Nishizuka Y. Lipid mediators and protein kinase C activation for the intracellular signaling network. J Biochem (Tokyo) 115: 1029-1034, 1994.
24. Puceat M, Hilal-Dandan R, Strulovici B, Brunton LL, and Brown JH. Differential regulation of protein kinase C isoforms in isolated neonatal and adult rat cardiomyocytes. J Biol Chem 269:16938-16944, 1994.
25. Rybin VO and Steinberg SF. Protein kinase C isoform expression and regulation in the developing heart. Circ Res 74: 299-309, 1994.
26. Shin HG, Barnett JV, Chang P, Reddy S, Drinkwater DC, Pierson RN, Wiley RG, and Murray KT. Molecular heterogeneity of protein kinase C expression in human ventricle. Cardiovasc Res 48: 285-299, 2000.
27. Speechly-Dick ME, Macanu MM, and Yellon DM. Protein kinase C. Its role in ischemic preconditioning in the rat. Circ Res 75: 586-590, 1994.
28. Strasser RH, Simonis G, Schon SP, Braun MU, Ihl-Vahl R, Weinbrenner C, Marquetant R, and Kubler W. Two distinct mechanisms mediate a different regulation of protein kinase C isozymes in acute and prolonged myocardial ischemia. Circ Res 85: 77-87, 1999.
29. Toullec D, Pianetti P, Coste H, Bellevergue P, Grand-Perret T, Ajakane M, Baudet V, Boissin P, Boursier E, and Loriolle F. The bisindolylmaleimide GF 109203X is a potent and selective inhibitor of protein kinase C. J Biol Chem 266: 15771-15781, 1991.
30. 2. Implications for cardiac cycle-dependent alterations in phospholipolysis. J Biol Chem 271: 20989-20992, 1996.